Abiopharma

🔍 Smith Jill D. (Director)

Company: Evolent Health, Inc. (EVH)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 23,137 shares of Class A Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 23,137.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents restricted stock units granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
• F2: Securities vest on the earlier of January 2, 2027, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.